Table 2.
1 |
2 |
3 |
4 |
5 |
ANOVA P-value | Bonferroni at 0.05 | |
---|---|---|---|---|---|---|---|
Control 2 (n = 730) | Cataract (n = 195) | AMD (n = 119) | Glaucoma (n = 51) | Retinopathy (n = 73) | |||
Age (years) | 78.5 ± 6.7 | 78.3 ± 8.4 | 78.4 ± 6.9 | 77.9 ± 8.2 | 78.2 ± 6.7 | ns | ns |
MMSE score | 22.5 ± 6.0 | 22.0 ± 5.5 | 20.9 ± 6.3 | 21.3 ± 5.9 | 21.5 ± 5.9 | 0.044 | ns |
GDS score | 8.3 ± 4.0 | 9.2 ± 4.0 | 8.6 ± 3.9 | 8.3 ± 4.0 | 9.3 ± 4.0 | 0.029 | ns |
ADLs score | 68.5 ± 24.4 | 65.7 ± 21.5 | 68.5 ± 21.9 | 68.7 ± 23.1 | 70.1 ± 22.9 | ns | ns |
IADL score | 2.8 ± 2.3 | 2.2 ± 1.9 | 2.4 ± 2.0 | 3.0 ± 2.1 | 2.4 ± 2.0 | 0.004 | ns |
CIRS score | 30.6 ± 5.1 | 32.2 ± 4.7 | 30.6 : 6.2 | 32.6 ± 5.3 | 32.0 ± 6.4 | ns | ns |
CIRS-MI | 3.6 ± 0.5 | 3.7 ± 0.5 | 3.6 ± 0.5 | 3.6 ± 0.5 | 3.5 ± 0.5 | ns | ns |
CIRS-SI | 2.1 ± 0.4 | 2.2 ± 0.3 | 2.1 ± 0.5 | 2.3 ± 0.4 | 2.2 ± 0.5 | ns | ns |
CIRS-CI | 6.5 ± 2.3 | 7.0 ± 2.3 | 6.5 ± 2.9 | 7.6 ± 2.2 | 7.2 ± 3.1 | 0.000 | ns |
Results are shown as mean ± SD.
Statistically significant differences according to ANOVA are indicated in bold type.
AMD, age-related macular degeneration; MMSE, mini mental state examination; GDS, geriatric depression scale; ADL, activities of daily living; IADL, instrumental activities of daily living; CIRS, cumulative illness rating scale; CIRS-MI, maximum impairment; CIRS-SI, severity index; CIRS-CI, comorbidity index.